EMD-34673

Single-particle
3.1 Å
EMD-34673 Deposition: 04/11/2022
Map released: 08/11/2023
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-34673

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8hdh summary report (pdf.gz) Map-8hdh FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of human SGLT2-MAP17 complex with Canagliflozin

EMD-34673

Single-particle
3.1 Å
EMD-34673 Deposition: 04/11/2022
Map released: 08/11/2023
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Binary complex of Sodium/glucose cotransporter 2 with PDZK1-interacting protein 1.
Fitted models: 8hdh

Deposition Authors: Hiraizumi M , Kishida H, Miyaguchi I, Nureki O
Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter.
Hiraizumi M , Akashi T , Murasaki K, Kishida H, Kumanomidou T, Torimoto N, Nureki O , Miyaguchi I
(2024) Nat Struct Mol Biol , 31 , 159 - 169
PUBMED: 38057552
DOI: doi:10.1038/s41594-023-01134-0
ISSN: 1545-9985
Grant Support: